Tue, 24 Jan 2012 | BUSINESS SALE
According to media reports, US investors are in talks over buying commercial property space at Trafford Park and Heywood Distribution Park.
The Manchester Evening News (MEN) reports that SEGRO is in talks about selling 2 million square feet of factory and warehouse space at the site as well as a further 2.6 million square feet at Heywood Distribution Park, Middleton. The MEN states that both sites, housing big name brands, are amongst the UK’s industrial property “crown jewels”.
If the deal is agreed, new factories, shops and leisure spaces could be developed. According to the MEN, the sale price is expected to be over £200 million and US private equity firm Harbert Management is believed to be close to closing the deal.
MEN quotes one unnamed source as saying, “They [Harbert] will be looking at redevelopment because there’s a lot of old property there from the 1970s and before. They will also be looking to refurbish the better quality buildings." If the deal is agreed it would be SEGRO’s second sale to Harbert.
SEGRO bought the Trafford Park site in 2009 and announced plans for redevelopment. However, some of these were held up by the recession. SEGRO has said that it believes some parts of the site would be better used as retail or leisure space than for industrial uses.
The company is a leading manufacturer of cabling equipment for use across a variety of industries. With UK market dominance, the company also has an international customer base and receives recurring business through service and maintenance contracts...
A long-established distributor of bicycle components, accessories and maintenance products which supplies more than 1,000 retail and online shops across the UK has been placed in administration. Offers are now invited by 5pm on Monday, June 30, 2025.
The company is a prominent provider of installation, commissioning, and repair services for water purification systems, serving over 30 active clients across diverse sectors such as energy, industrial, healthcare, and pharmaceuticals. With a strong r...
Please choose your settings for this site below. For more information please read our Cookie Policy
These cookies are necessary for our website to function properly and provide you with access to all features.
These are analytics cookies that help us to improve the way our website works.
These are used to improve the functional performance of the website and make it easier for you to use.